Companies /Consumer Defensive

Procter & Gamble Company

NYSE: PG Household & Personal Products
$146.27
▲ $0.59 (+0.41%) today
Markets closed · 4:36pm ET

PG Coverage

Page 31
8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick